(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 39.50%-552.47K | 61.83%-604.99K | 63.42%-420.34K | 47.85%-5.15M | 16.60%-1.5M | 49.36%-913.25K | 36.39%-1.58M | 69.59%-1.15M | 50.80%-9.88M | 65.17%-1.8M |
Net income from continuing operations | 4.23%-2.64M | 28.16%-2.58M | 32.01%-2.42M | -12.27%-16.3M | -119.34%-6.39M | 46.64%-2.76M | -1.93%-3.58M | -22.23%-3.56M | 45.49%-14.52M | 29.13%-2.91M |
Operating gains losses | -222.65%-72.09K | 54.38%-46.06K | -1,909.69%-40.84K | -121.44%-103.23K | 75.33%-59.02K | -86.93%58.78K | 31.00%-100.95K | -100.49%-2.03K | 290.59%481.55K | -121.80%-239.25K |
Depreciation and amortization | -30.55%249.68K | -4.75%343.55K | 15.03%383.12K | -10.44%1.41M | 8.03%361.19K | 28.19%359.5K | -52.74%360.69K | 65.49%333.06K | 25.69%1.58M | 21.30%334.34K |
Asset impairment expenditure | ---- | ---- | ---- | 233.96%4.23M | --4.23M | ---- | ---- | ---- | -32.56%1.27M | ---- |
Remuneration paid in stock | ---- | ---- | ---- | 2,129.93%24.66K | ---- | ---- | ---- | ---- | -99.44%1.11K | -100.05%-32 |
Unrealized gains and losses of investment securities | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 84.30%-26.08K | ---- | ---- |
Remuneration paid in stock | -78.36%103.99K | 87.76%944.13K | -112.73%-101.48K | -30.46%1.54M | -140.94%-244.76K | -28.58%480.62K | 26.30%502.83K | 47.65%797.4K | -67.61%2.21M | -36.90%597.84K |
Other non cashItems | 27.39%947.61K | 41.52%979.08K | -6.03%722.38K | 104.42%1.82M | -252.07%-380.01K | 30.92%743.86K | 699.97%691.84K | 305.19%768.77K | -76.28%892.52K | -30.99%249.9K |
Change In working capital | -103.52%-7.19K | -148.27%-250.55K | 92.20%1.04M | 223.81%2.22M | 184.14%953.71K | -84.92%204.49K | 1,363.22%519.11K | 126.33%539.33K | 76.37%-1.79M | 58.18%-1.13M |
-Change in receivables | -263.48%-857.75K | -126.51%-53.6K | -57.67%172.81K | 205.26%420.85K | 107.10%46.4K | -131.46%-235.99K | 211.52%202.18K | 229.60%408.25K | -418.63%-399.8K | -375.86%-653.57K |
-Change in inventory | 327.47%280.66K | -429.33%-152.59K | 156.04%100.5K | 173.97%746.06K | 204.81%1.08M | -234.93%-123.39K | -104.92%-28.83K | 66.11%-179.33K | 70.53%-1.01M | -37.61%-1.03M |
-Change in prepaid assets | -473.87%-77.52K | 383.99%49.09K | 26.09%-51.6K | 1,265.57%382.8K | 615.27%421.73K | -87.36%20.73K | -85.34%10.14K | 62.10%-69.81K | -116.92%-32.84K | 73.13%-81.85K |
-Change in payables and accrued expense | 19.20%647.42K | -127.84%-93.45K | 114.32%814.86K | 291.00%666.94K | -179.46%-592.01K | 26.73%543.13K | 166.26%335.61K | 137.41%380.21K | 92.19%-349.18K | 139.30%745K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 39.50%-552.47K | 61.83%-604.99K | 63.42%-420.34K | 47.85%-5.15M | 16.60%-1.5M | 49.36%-913.25K | 36.39%-1.58M | 69.59%-1.15M | 50.80%-9.88M | 65.17%-1.8M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 0 | -81.38%41.14K | 170.14%391.64K | -73.08%54.67K | 118.64%57.38K | 115.21%58.67K | 424.99%220.92K | 66.31%-558.34K | 147.62%203.08K |
Net PPE purchase and sale | -75.42%41.14K | 19.80%-41.14K | -1.68%41.14K | 159.92%212.56K | -47.81%54.67K | 152.43%167.34K | 29.08%-51.3K | 161.55%41.84K | 68.83%-354.72K | 124.87%104.74K |
Net investment purchase and sale | --0 | --0 | --0 | 187.95%179.08K | --0 | --0 | --0 | --179.08K | -126.20%-203.63K | --98.33K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | --0 | -81.38%41.14K | 170.14%391.64K | -73.08%54.67K | 118.64%57.38K | 115.21%58.67K | 424.99%220.92K | 66.31%-558.34K | 147.62%203.08K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -30.51%538.85K | -59.85%472.02K | -59.22%490.63K | -12.61%4.63M | 7.30%1.47M | -48.98%775.45K | -52.51%1.18M | 1,758.01%1.2M | -70.91%5.3M | -71.99%1.37M |
Net issuance payments of debt | -108.79%-68.15K | -75.84%284.02K | -78.92%253.63K | -10.53%4.63M | 10.52%1.47M | -48.98%775.45K | -52.51%1.18M | 872.40%1.2M | 12.15%5.17M | -72.71%1.33M |
Net common stock issuance | ---- | --188K | --237K | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -93.72%83.2K | --0 |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 103.13%40K | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -30.51%538.85K | -59.85%472.02K | -59.22%490.63K | -12.61%4.63M | 7.30%1.47M | -48.98%775.45K | -52.51%1.18M | 1,758.01%1.2M | -70.91%5.3M | -71.99%1.37M |
Net cash flow | ||||||||||
Beginning cash position | -62.37%39.69K | -61.57%177.23K | -64.05%62.18K | -96.76%172.98K | -94.32%24.17K | -89.63%105.46K | -67.51%461.19K | -96.76%172.98K | -39.75%5.34M | -92.94%425.84K |
Current changes in cash | 83.06%-13.63K | 62.09%-132.97K | -59.49%111.43K | 97.47%-129.86K | 111.69%26.29K | 86.40%-80.42K | 12.81%-350.77K | 107.02%275.04K | -45.89%-5.14M | 67.65%-224.76K |
Effect of exchange rate changes | 13.71%-749 | 7.96%-4.57K | -72.47%3.62K | 167.84%19.06K | 141.74%11.73K | ---868 | ---4.96K | --13.16K | ---28.09K | ---28.09K |
End cash Position | 4.74%25.31K | -62.37%39.69K | -61.57%177.23K | -64.05%62.18K | -64.05%62.18K | -94.32%24.17K | -89.63%105.46K | -67.51%461.19K | -96.76%172.98K | -96.76%172.98K |
Free cash from | 39.54%-552.47K | 61.76%-604.99K | 63.80%-420.34K | 50.32%-5.17M | 19.11%-1.51M | 56.95%-913.78K | 38.29%-1.58M | 69.81%-1.16M | 50.98%-10.4M | 66.67%-1.86M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data